WISeKey Signs MoUs with La Linea and Gibraltar Governments to Develop a Joint 4th Industrial Revolution Center of Excellence Spearheading Innovation in the Region
September 20, 2021 01:00 ET
|
Wisekey International Holding SA
WISeKey Signs MoUs with La Linea and Gibraltar Governments to Develop a Joint 4th Industrial Revolution Center of Excellence Spearheading Innovation in the Region Mr. Fabian Picardo, Chief Minister...
WISeKey firma memorandos de entendimiento con los gobiernos de La Línea y Gibraltar para desarrollar un Centro de Excelencia de la 4.a Revolución Industrial para liderar la innovación en la región
September 20, 2021 01:00 ET
|
Wisekey International Holding SA
WISeKey firma memorandos de entendimiento con los gobiernos de La Línea y Gibraltar para desarrollar un Centro de Excelencia de la 4.a Revolución Industrial para liderar la innovación en la región ...
HUTCHMED Initiates a Japan Bridging Study to Support Surufatinib Registration for Advanced Neuroendocrine Tumors
September 19, 2021 20:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Sept. 19, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that it has initiated a...
Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus Infections in All-Comer General Population by COVISTIX as Compared to a Globally Leading Rapid Antigen Test
September 19, 2021 14:58 ET
|
Sorrento Therapeutics, Inc.
As a general screening for all-comers (i.e. COVID-19 symptomatic and asymptomatic populations), COVISTIX (n=783) has an 81% sensitivity vs. 62% (n=2202) sensitivity by globally leading Panbio rapid...
FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations
September 18, 2021 03:40 ET
|
BioNTech SE
Committee reviewed clinical data showing a booster dose of COMIRNATY® elicits high neutralization titers against SARS-CoV-2 and all currently tested variants Reactogenicity profile within seven days...
FDA-Beratungsausschuss unterstützt einstimmig Notfallzulassung für COMIRNATY®-Auffrischungsimpfung bei Personen ab 65 Jahren und bestimmten Risikogruppen
September 18, 2021 03:40 ET
|
BioNTech SE
Der FDA-Beratungsausschuss prüfte klinische Daten zu einer Auffrischungsimpfung mit COMIRNATY®, die hohe neutralisierende Antikörpertiter gegen SARS-CoV-2 und alle bisher untersuchten Varianten...
ATIF Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 17, 2021 22:02 ET
|
ATIF Holdings Limited
LOS ANGELES, Sept. 17, 2021 (GLOBE NEWSWIRE) -- ATIF Holdings Limited (Nasdaq: ATIF, the “Company”), a holding group providing business and financial consulting in Asia and North America, today...
Repurchase of shares in Millicom
September 17, 2021 17:00 ET
|
Millicom International Cellular S.A.
Repurchase of shares in Millicom Luxembourg, September 17, 2021 - During the period September 9, 2021 – September 15, 2021, Millicom repurchased a total of 131,559 of its Swedish Depository...
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 17, 2021 16:52 ET
|
Ocugen
MALVERN, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
September 17, 2021 16:10 ET
|
Organovo, Inc.
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00...